Potato crisps from CRISPR-Cas9 modification: aspects of autonomy and fairness
Publikation: Bidrag til bog/antologi/rapport › Konferencebidrag i proceedings › Forskning
Standard
Potato crisps from CRISPR-Cas9 modification : aspects of autonomy and fairness. / Röcklinsberg, Helena; Gjerris, Mickey.
Professionals in food chains: EurSafe 2018. red. / Svenja Springer; Herwig Grimm. Wageningen Academic Publishers, 2018. s. 430-435.Publikation: Bidrag til bog/antologi/rapport › Konferencebidrag i proceedings › Forskning
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - GEN
T1 - Potato crisps from CRISPR-Cas9 modification
T2 - Congress of the European Society for Agricultural and Food Ethics
AU - Röcklinsberg, Helena
AU - Gjerris, Mickey
N1 - Conference code: 14
PY - 2018
Y1 - 2018
N2 - Within the Swedish MISTRA Biotech research programme the quality of starch in potatoes has been changed by use of different technologies such asCRISPR-Cas9. The idea is to increase the level of amylose, both for health reasons and as a mean to investigate possibilities for replacing fossil based oxygen barriers in food packages, thus reducing the climate impact. The goals thus seem laudable to most, but the experience of introducing GMOs on the market shows that even though there might be agreement on the goals, the strategy of using biotechnology to achieve them can be ethically contested. We describe the intentions behind developing the new plants and analyse some of the ethical issues that the development and marketing of the gene-edited potatoes raise. We argue that the concepts of autonomy and fairness are useful tools to understand many of the conflicting ethical values in the discussions relating to gene-editing. From our perspective these concepts are interrelated and relevant in at least two ways: (1) fairness in terms of both financial power and labelling as a means to ensure equal opportunities to make an autonomous decision as an individual ethical consumer and (2) fairness in term of equal market power between autonomous market actors.
AB - Within the Swedish MISTRA Biotech research programme the quality of starch in potatoes has been changed by use of different technologies such asCRISPR-Cas9. The idea is to increase the level of amylose, both for health reasons and as a mean to investigate possibilities for replacing fossil based oxygen barriers in food packages, thus reducing the climate impact. The goals thus seem laudable to most, but the experience of introducing GMOs on the market shows that even though there might be agreement on the goals, the strategy of using biotechnology to achieve them can be ethically contested. We describe the intentions behind developing the new plants and analyse some of the ethical issues that the development and marketing of the gene-edited potatoes raise. We argue that the concepts of autonomy and fairness are useful tools to understand many of the conflicting ethical values in the discussions relating to gene-editing. From our perspective these concepts are interrelated and relevant in at least two ways: (1) fairness in terms of both financial power and labelling as a means to ensure equal opportunities to make an autonomous decision as an individual ethical consumer and (2) fairness in term of equal market power between autonomous market actors.
U2 - 10.3920/978-90-8686-869-8_68
DO - 10.3920/978-90-8686-869-8_68
M3 - Article in proceedings
SN - 978-90-8686-321-1
SP - 430
EP - 435
BT - Professionals in food chains
A2 - Springer, Svenja
A2 - Grimm, Herwig
PB - Wageningen Academic Publishers
Y2 - 13 June 2018 through 16 June 2018
ER -
ID: 199029587